GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Taloph Pharmaceutical Stock Co Ltd (SHSE:600222) » Definitions » EV-to-EBITDA

Henan Taloph Pharmaceutical Stock Co (SHSE:600222) EV-to-EBITDA : 49.71 (As of Jun. 21, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Henan Taloph Pharmaceutical Stock Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Henan Taloph Pharmaceutical Stock Co's enterprise value is ¥2,960 Mil. Henan Taloph Pharmaceutical Stock Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥60 Mil. Therefore, Henan Taloph Pharmaceutical Stock Co's EV-to-EBITDA for today is 49.71.

The historical rank and industry rank for Henan Taloph Pharmaceutical Stock Co's EV-to-EBITDA or its related term are showing as below:

SHSE:600222' s EV-to-EBITDA Range Over the Past 10 Years
Min: -305.98   Med: 58.66   Max: 427.46
Current: 49.71

During the past 13 years, the highest EV-to-EBITDA of Henan Taloph Pharmaceutical Stock Co was 427.46. The lowest was -305.98. And the median was 58.66.

SHSE:600222's EV-to-EBITDA is ranked worse than
90.7% of 710 companies
in the Drug Manufacturers industry
Industry Median: 14.265 vs SHSE:600222: 49.71

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-21), Henan Taloph Pharmaceutical Stock Co's stock price is ¥4.28. Henan Taloph Pharmaceutical Stock Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.109. Therefore, Henan Taloph Pharmaceutical Stock Co's PE Ratio for today is 39.27.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Henan Taloph Pharmaceutical Stock Co EV-to-EBITDA Historical Data

The historical data trend for Henan Taloph Pharmaceutical Stock Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henan Taloph Pharmaceutical Stock Co EV-to-EBITDA Chart

Henan Taloph Pharmaceutical Stock Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.97 25.24 82.17 -251.35 35.09

Henan Taloph Pharmaceutical Stock Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -45.35 -36.48 -75.03 35.09 60.44

Competitive Comparison of Henan Taloph Pharmaceutical Stock Co's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Henan Taloph Pharmaceutical Stock Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Henan Taloph Pharmaceutical Stock Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Henan Taloph Pharmaceutical Stock Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Henan Taloph Pharmaceutical Stock Co's EV-to-EBITDA falls into.



Henan Taloph Pharmaceutical Stock Co EV-to-EBITDA Calculation

Henan Taloph Pharmaceutical Stock Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2959.952/59.546
=49.71

Henan Taloph Pharmaceutical Stock Co's current Enterprise Value is ¥2,960 Mil.
Henan Taloph Pharmaceutical Stock Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Henan Taloph Pharmaceutical Stock Co  (SHSE:600222) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Henan Taloph Pharmaceutical Stock Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4.28/0.109
=39.27

Henan Taloph Pharmaceutical Stock Co's share price for today is ¥4.28.
Henan Taloph Pharmaceutical Stock Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.109.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Henan Taloph Pharmaceutical Stock Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Henan Taloph Pharmaceutical Stock Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Jinsuo Road, High-tech Industrial Development Zone, Henan Province, Zhengzhou, CHN, 450001
Henan Taloph Pharmaceutical Stock Co Ltd is a Chinese company engaged in the manufacture of Western and Chinese medicine products, including oral liquids, tablets, capsules, and bulk drugs. Geographically, the business activities are functioned through China region.
Executives
Zhao Qing Xin Director

Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Headlines

No Headlines